After Harvard resigned, students and doctors thought about medical school rankings.

Published Date: 22 Apr 2023

The US News and World Report rankings, once the benchmark by which students evaluated medical schools, have recently begun to lose some of their sway. The value of a school can be evaluated in various ways, according to medical students.

Read Full News

Latest News

Tests in Italy, Spain Come Back Negative in Global Hunt for Hantavirus

Seventeen people under observation in Italy and Spain for possible hantavirus infection have tested negative, the countries' health ministries said on Wednesday as...

Britain to Bring 10 People to UK for Precautionary Isolation After Hantavirus Outbreak

Britain said on Tuesday that 10 people from remote island territories, including cruise ship passengers and ⁠medical staff who had contact with confirmed cases in the...

NICE Clears Home Antibiotics for Stable Newborns

Updated NICE guidance allows stable newborns to switch to oral antibiotics and complete their course at home, potentially cutting hospital stays by nearly 3 days.

Guideline Advises on New Drug for ILD in Rheumatic Diseases

The British Society for Rheumatology has produced its first guidelines for the diagnosis and management of systemic autoimmune rheumatic disease-associated interstitial lung disease.

Transplant-Related Immunosuppression Drives SCC Outcomes

While most clinicians are aware of the link between immunosuppression and poor outcomes, this study validates that link and clarifies the type of immunosuppression associated with the greatest risk.

TNF Plus IL-23 Inhibition for PsA: Better Than IL-23 Alone?

Patients with active psoriatic arthritis who have an inadequate response to TNF inhibitors, mainly those with elevated C-reactive protein levels, may benefit from guselkumab plus golimumab therapy.

Todays Updates

All-Oral Treatment Combo for AML Earns FDA Nod

The combo, decitabine and cedazuridine tablets plus venetoclax, was approved for adults aged 75 and older and adults with comorbidities that preclude intensive induction chemotherapy.

Todays Updates

All-Oral Treatment Combo for AML Earns FDA Nod

The combo, decitabine and cedazuridine tablets plus venetoclax, was approved for adults aged 75 and older and adults with comorbidities that preclude intensive induction chemotherapy.

Latest News

Seventeen people under observation in Italy and Spain for possible hantavirus infection have tested negative, the countries' health ministries said on Wednesday as...

Britain said on Tuesday that 10 people from remote island territories, including cruise ship passengers and ⁠medical staff who had contact with confirmed cases in the...

Updated NICE guidance allows stable newborns to switch to oral antibiotics and complete their course at home, potentially cutting hospital stays by nearly 3 days.

The British Society for Rheumatology has produced its first guidelines for the diagnosis and management of systemic autoimmune rheumatic disease-associated interstitial lung disease.

While most clinicians are aware of the link between immunosuppression and poor outcomes, this study validates that link and clarifies the type of immunosuppression associated with the greatest risk.

Patients with active psoriatic arthritis who have an inadequate response to TNF inhibitors, mainly those with elevated C-reactive protein levels, may benefit from guselkumab plus golimumab therapy.

News All Time

Exclusive-Kennedy's Health Officials Explored US Ban Of Some Widely Used Antidepressants, Sources Say

U.S. health department officials last week explored whether they could ban certain drugs in a widely prescribed class of antidepressants as Health Secretary Robert F....

Early Trauma May Shape Outcomes in Childhood-Onset Lupus

Adverse childhood experiences are common in children with systemic lupus erythematosus and are linked to higher odds of neuropsychiatric lupus, a cohort study finds.

Reduced Kidney Function Tied to Lower Remission Rates in RA

For patients with rheumatoid arthritis and reduced kidney function, remission after drug therapy is less likely than for patients with preserved kidney function.

Four Factors Keep ‘At-Risk’ Group Arthritis-Free at 10 Years

People with ‘good’ prognostic factors at baseline are less likely to progress to rheumatoid arthritis at 5 and 10 years after presentation, a cohort study finds.

Mental Health Conditions Tied to Cancer Risk, Study Reveals

Depression, anxiety, and bipolar disorders are associated with increased risks for overall and site-specific cancers, a population-based study reports.

FDA Seeks Advice on Researching Drug Risks in Pregnancy

The FDA held a workshop on ways to improve collection of safety data on medicines used during pregnancy and released guidance for companies on postapproval pregnancy safety studies.

MHRA Approves New Prophylactic for Rare Swelling Disorder

The MHRA has approved donidalorsen for long-term prevention of hereditary angioedema, a rare disorder causing potentially life-threatening swelling.

New Paper Highlights Evidence for Congenital Lyme Disease

Evidence suggests Borrelia burgdorferi can cross the placenta and may be associated with adverse pregnancy outcomes.

Small Study Shows One-time Cell Therapy Can Control HIV Infection

Re-engineering an HIV patient's own immune cells to find and destroy the virus succeeded in controlling the infection in a small first-in-human study, but researchers said...

Gestational Weight Gain May Shape Allergic Disease Risk

Children may have higher odds of developing asthma, rhinitis, and allergic sensitization if their mothers have excessive weight gain during gestation, a study shows.

Hepatorenal Syndrome Essentials: Strategies for Early and Effective Treatment

Hepatorenal Syndrome Essentials: Strategies for Early and Effective Treatment

Optimizing COVID-19 Care for Hospitalized Patients

Optimizing COVID-19 Care for Hospitalized Patients

Procalcitonin-Guided Sepsis Care Improves Survival, Had No Effect on Antibiotic Use

Clinicians agreed with the algorithm's recommendation in 47% of cases

International Perspectives on Individualizing Care for Hospitalized Patients With COVID-19

International Perspectives on Individualizing Care for Hospitalized Patients With COVID-19

In the Hot Seat at ACC: PE Clot-Buster, Impella-Protected PCI, Utility of CAC=0

Results of lung impedance-guided therapy in HFpEF also anticipated this weekend

Ceragenin-Coated Endotracheal Tubes Fail to Reduce Ventilator-Associated Pneumonia

Intervention was tied to other improvements versus standard ETTs

Recommended News For You

A new therapeutic approach could help tackle radiation resistance in childhood brain tumors

Health researchers discuss Medicaid cancer screening trends, best practices

Do Anatomy Atlases Reflect Social Inequalities?

Adding Chemo to Osimertinib Doubles PFS in Advanced NSCLC

Which Salvage Therapy Is Best for Recurrent Prostate Cancer?

Advanced Solid Tumors May Benefit from Investigative Immunotherapy Combo.

Mutation Clearance After Transplant Linked to Better Outcomes in Myelofibrosis

Recommended Articles For You

The Role of Calcium Corrections in Accurate Blood Test Results  

Cancer Staging: Updates, Clinical Insights, and Educational Resources for Medical Professionals 

A Comprehensive Guide to Living with Cutaneous T Cell Lymphoma: Tips & Strategies  

Breaking Barriers in Cancer Treatment: The Role of Innovative Oncology Drugs 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

The response of bipolar patients to lithium may be predicted by ancestry.

2.

New imaging probe helps track prostate cancer and possibly treat it before resistance develops

3.

Do Anatomy Atlases Reflect Social Inequalities?

4.

Modified personalized cancer vaccine generates powerful immune response

5.

Enthusiasm for Transplant-Free Strategies for Low-Risk Relapsed Hodgkin Lymphoma

1.

CENP-H in Cancer: A Key Player in Tumor Progression and a Potential Therapeutic Target

2.

Uncovering Dyscrasia: A Comprehensive Guide to Diagnosis and Treatment

3.

Understanding SVR Normal Range: A Guide to Achieving Optimal Health

4.

Matrix Metalloproteinases in Stroke: Broad vs. Selective Inhibition Strategies

5.

AI in Cancer Diagnostics and Imaging Interpretation

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Should We Use DARA Up Front As First-Line Therapy in MM?

2.

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

3.

Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care

4.

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion

5.

"Lorlatinib Upfront": A Niche but Powerful Option For ALK+ NSCLC

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot